1-4 of 4
David M. Kurtz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

Free
Clinical Trials & Observations
Mark P. Hamilton, Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Nadia Kirmani, Zachary Ehlinger, Shriya Syal, Zinaida Good, Brian Sworder, Joseph Schroers-Martin, Ying Lu, Lori Muffly, Robert S. Negrin, Sally Arai, Robert Lowsky, Everett Meyer, Andrew R. Rezvani, Judith Shizuru, Wen-Kai Weng, Parveen Shiraz, Surbhi Sidana, Sushma Bharadwaj, Melody Smith, Saurabh Dahiya, Bita Sahaf, David M. Kurtz, Crystal L. Mackall, Robert Tibshirani, Ash A. Alizadeh, Matthew J. Frank, David B. Miklos
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3314–3326.
https://doi.org/10.1182/bloodadvances.2024012637
Published: 2024
Includes: Supplemental data
Journal Articles

Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas

Free
Navika D. Shukla, Joseph G. Schroers-Martin, Brian J. Sworder, Karan Raj Kathuria, Stefan K. Alig, Matthew J. Frank, David B. Miklos, Steven Coutre, Maximilian Diehn, Michael S. Khodadoust, Mark Roschewski, David M. Kurtz, Ash A. Alizadeh
Journal: Blood Advances
Blood Adv (2024) 8 (3): 780–784.
https://doi.org/10.1182/bloodadvances.2023011997
Published: 2024
Journal Articles

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas

Free
Clinical Trials & Observations
Ryan C. Lynch, Christina Poh, Chaitra S. Ujjani, Edus H. Warren, III, Stephen D. Smith, Mazyar Shadman, Karolyn Morris, Sydney Lee, Heather Rasmussen, Susan Ottemiller, Megan Shelby, Sarith Keo, Kaitlin Verni, David M. Kurtz, Ash A. Alizadeh, Jacob J. Chabon, Gregory J. Hogan, Andre Schulz, Ted Gooley, Jenna M. Voutsinas, Ajay K. Gopal
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2449–2458.
https://doi.org/10.1182/bloodadvances.2022009145
Published: 2023
Includes: Supplemental data
Journal Articles

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

Free
Clinical Trials & Observations
Hua-Jay J. Cherng, Stefan K. Alig, Yasuhiro Oki, Loretta J. Nastoupil, Luis Fayad, Sattva S. Neelapu, Francesco Turturro, Fredrick Hagemeister, Alexander F. M. Craig, Charles W. Macaulay, Maria Alma Rodriguez, Hun Ju Lee, Timothy J. McDonnell, Christopher R. Flowers, Francisco Vega, Michael R. Green, Lei Feng, David M. Kurtz, Ash A. Alizadeh, R. Eric Davis, Jason R. Westin
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1137–1145.
https://doi.org/10.1182/bloodadvances.2022008174
Published: 2023